Equities research analysts at Loop Capital began coverage on shares of Tempus AI (NASDAQ:TEM – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. Loop Capital’s price target points to a potential upside of 37.14% from the company’s current price.
Separately, JPMorgan Chase & Co. assumed coverage on shares of Tempus AI in a research note on Tuesday. They issued an “overweight” rating and a $42.00 price objective for the company. Nine research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $45.63.
Get Our Latest Stock Report on Tempus AI
Tempus AI Trading Up 1.4 %
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
- Five stocks we like better than Tempus AI
- What Do S&P 500 Stocks Tell Investors About the Market?
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- How to Calculate Retirement Income: MarketBeat’s Calculator
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.